Market Overview

UPDATE: Stifel Nicolaus Raises PT to $117 on Stericycle Following Solid Q4

Related SRCL
Jim Cramer Gives His Opinion On Stericycle And Ford
CNBC's List Of 20 Beaten-Up Stocks
Asymmetric Allocation: 3 Reasons Why SRCL/SMED Is A Great Long/Short Reversion To The Mean Story (Seeking Alpha)

Stifel Nicolaus reiterated its Buy rating on Stericycle (NASDAQ: SRCL) and raised the price target from $102.00 to $117.00.

Stifel Nicolaus commented, "SRCL posted another solid quarter and raised guidance again. Revenue and EPS were ahead of estimates, though FCF came in within the expected range. We believe SRCL has largely completed the platform acquisitions it was making in the Patient Communications space that were weighing on company margins (they were declining), and margins have improved in each of the last two quarters."

Stericycle closed at $95.12 on Wednesday.

Latest Ratings for SRCL

Nov 2016Goldman SachsDowngradesNeutralSell
Oct 2016Stifel NicolausUpgradesHoldBuy
Sep 2016BairdMaintainsNeutral

View More Analyst Ratings for SRCL
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings


Related Articles (SRCL)

View Comments and Join the Discussion!